Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1987 3
1988 1
1989 2
1990 6
1991 3
1992 6
1993 1
1994 9
1995 8
1996 13
1997 15
1998 18
1999 13
2000 28
2001 20
2002 32
2003 24
2004 46
2005 53
2006 71
2007 86
2008 107
2009 141
2010 145
2011 218
2012 235
2013 274
2014 289
2015 307
2016 313
2017 377
2018 372
2019 443
2020 501
2021 512
2022 545
2023 5
Text availability
Article attribute
Article type
Publication date

Search Results

4,690 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy, safety, and biomarker analysis of Camrelizumab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma (CAPTAIN study).
Yang Y, Zhou T, Chen X, Li J, Pan J, He X, Lin L, Shi YR, Feng W, Xiong J, Yang K, Yu Q, Zhang Q, Hu D, Sun Y, Hu G, Li P, Shen L, Lin Q, Zhang B, Qu X, Zou J, Zhang L, Fang W, Zhao Y. Yang Y, et al. Among authors: qu x. J Immunother Cancer. 2021 Dec;9(12):e003790. doi: 10.1136/jitc-2021-003790. J Immunother Cancer. 2021. PMID: 34933967 Free PMC article. Clinical Trial.
ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer.
Johnson RM, Qu X, Lin CF, Huw LY, Venkatanarayan A, Sokol E, Ou FS, Ihuegbu N, Zill OA, Kabbarah O, Wang L, Bourgon R, de Sousa E Melo F, Bolen C, Daemen A, Venook AP, Innocenti F, Lenz HJ, Bais C. Johnson RM, et al. Among authors: qu x. Nat Commun. 2022 Sep 19;13(1):5478. doi: 10.1038/s41467-022-33172-5. Nat Commun. 2022. PMID: 36117191 Free PMC article.
The role of TRPV channels in osteoporosis.
Liu N, Lu W, Dai X, Qu X, Zhu C. Liu N, et al. Among authors: qu x. Mol Biol Rep. 2022 Jan;49(1):577-585. doi: 10.1007/s11033-021-06794-z. Epub 2021 Oct 25. Mol Biol Rep. 2022. PMID: 34694549 Review.
Kokarden-Nävus: Ein Fallbericht.
Liang Y, Cao J, Xuan X, Qu X, Wu T, Ye H, Chen F, Zhu L, Huang C. Liang Y, et al. Among authors: qu x. J Dtsch Dermatol Ges. 2022 Mar;20(3):351-354. doi: 10.1111/ddg.14705_g. J Dtsch Dermatol Ges. 2022. PMID: 35304946 No abstract available.
Tumor Immunogenomic Features Determine Outcomes in Patients with Metastatic Colorectal Cancer Treated with Standard-of-Care Combinations of Bevacizumab and Cetuximab.
Innocenti F, Yazdani A, Rashid N, Qu X, Ou FS, Van Buren S, Bertagnolli MM, Kabbarah O, Blanke CD, Venook AP, Lenz HJ, Vincent BG. Innocenti F, et al. Among authors: qu x. Clin Cancer Res. 2022 Apr 14;28(8):1690-1700. doi: 10.1158/1078-0432.CCR-21-3202. Clin Cancer Res. 2022. PMID: 35176136 Free PMC article. Clinical Trial.
4,690 results